ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 72 filers reported holding ALLAKOS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $355,190 | -24.4% | 79,818 | +43.1% | 0.00% | 0.0% |
Q4 2022 | $469,685 | +0.6% | 55,782 | -32.0% | 0.00% | 0.0% |
Q1 2022 | $467,000 | +102.2% | 81,994 | +4878.4% | 0.00% | 0.0% |
Q4 2020 | $231,000 | +335.8% | 1,647 | +196.2% | 0.00% | – |
Q4 2019 | $53,000 | +20.5% | 556 | 0.0% | 0.00% | – |
Q3 2019 | $44,000 | -93.8% | 556 | -96.8% | 0.00% | -100.0% |
Q1 2019 | $710,000 | – | 17,538 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 2,268,188 | $184,744,000 | 7.82% |
Fairmount Funds Management LLC | 164,662 | $13,412,000 | 5.68% |
Samsara BioCapital, LLC | 192,334 | $15,666,000 | 4.37% |
Redmile Group, LLC | 2,425,560 | $197,562,000 | 3.63% |
Boxer Capital, LLC | 675,000 | $54,979,000 | 1.90% |
Rock Springs Capital Management LP | 241,582 | $19,677,000 | 0.50% |
Handelsinvest Investeringsforvaltning | 30,000 | $2,444,000 | 0.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $1,279,000 | 0.41% |
Eventide Asset Management | 160,000 | $13,032,000 | 0.26% |
Cormorant Asset Management, LP | 75,000 | $6,109,000 | 0.24% |